Comparing mandated health care reforms: The Affordable Care Act, accountable care organizations, and the medicare ESRD program

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 9, 2012, Pages 1535-1543

  Watnick, Suzanne ^a   Weiner, Daniel E ^b   Shaffer, Rachel ^c   Inrig, Jula ^d   Moe, Sharon ^e   Mehrotra, Rajnish ^f,g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c American Society of Nephrology   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCOUNTABLE CARE ORGANIZATION; COST CONTROL; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; KIDNEY FAILURE; LAW; MEDICAL INFORMATION SYSTEM; MEDICARE; NONHUMAN; PROSPECTIVE PAYMENT; QUALITY INCENTIVE PROGRAM; REVIEW;

ACCOUNTABLE CARE ORGANIZATIONS; COST SAVINGS; GOVERNMENT REGULATION; HEALTH CARE COSTS; HEALTH CARE REFORM; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; KIDNEY FAILURE, CHRONIC; MEDICARE; MODELS, ORGANIZATIONAL; PATIENT PROTECTION AND AFFORDABLE CARE ACT; QUALITY OF HEALTH CARE; REIMBURSEMENT, INCENTIVE; RENAL DIALYSIS; UNITED STATES;

EID: 84866057168     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01220212     Document Type: Review

References (35)

1. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; end-stage renal disease prospective payment system. Final rule. Fed Regist 75: 49029-49214, 2010
2. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; end-stage renal disease quality incentive program. Final rule. Fed Regist 76: 627-646, 2011
3. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; Medicare Shared Savings Program: Accountable Care Organizations. Final rule. Fed Regist 76: 67802-67990, 2011
4. Rittenhouse DR, Shortell SM, Fisher ES: Primary care and accountable care-two essential elements of delivery-system reform. N Engl J Med 361: 2301-2303, 2009
5. Rettig RA: Special treatment-the story of Medicare's ESRD entitlement. N Engl J Med 364: 596-598, 2011
6. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St PeterW, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, SolidC, Wang C, Weinhandl E, ZaunD, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 57[Suppl 1]: A8, e1-526, 2011
7. de Lissovoy G, Powe NR, Griffiths RI, Watson AJ, Anderson GF, Greer JW, Herbert RJ, Eggers PW, Milam RA, Whelton PK: The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. Med Care 32: 130-140, 1994
8. Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernán MA: Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA 297: 1667-1674, 2007
9. Steinbrook R: Medicare and erythropoietin. N Engl J Med 356: 4-6, 2007
10. US Senate: Medicare Improvements for Patients and Providers Act of 2008. Medicare, Provisions Relating Part B, Other Payment and Coverage Improvements. §153(a) Publ L No. 110-275 (2008)
11. Sedor JR, Watnick S, Patel UD, Cheung A, Harmon W, Himmelfarb J, Hostetter TH, Inrig JK, Mehrotra R, Robinson E, Smedberg PC, Shaffer RN; American Society of Nephrology ESRD Task Force: ASN End-Stage Renal Disease Task Force: Perspective on prospective payments for renal dialysis facilities. J Am Soc Nephrol 21: 1235-1237, 2010
12. Berwick DM: Making good on ACOs' promise-the final rule for the Medicare shared savings program. N Engl J Med 365: 1753-1756, 2011
13. Arbor Research Collaborative for Health: End-Stage Renal Disease (ESRD) Disease Management Demonstration Evaluation Report: Findings from 2006-2008, the First Three Years of a Five-Year Demonstration, 2010. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/Downloads/Arbor_ESRD_EvalReport_2010.pdf. Accessed March 14, 2012
14. Nissenson AR, Maddux FW, Velez RL, Mayne TJ, Parks J: Accountable care organizations and ESRD: The time has come. Am J Kidney Dis 59: 724-733, 2012
15. Winkelmayer WC, Chertow GM: The 2011 ESRD prospective payment system: An uncontrolled experiment. Am J Kidney Dis 57: 542-546, 2011
16. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule. Fed Regist 73: 20369-20484, 2008
17. Robinson B, Fuller D, Zinsser D, Albert J, Gillespie B, Tentori F, Turenne M, Port F, Pisoni R: The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: Rationale and methods for an initiative to monitor the new US bundled dialysis payment system. Am J Kidney Dis 57: 822-831, 2011
18. Spiegel DM, Khan I, Krishnan M, Mayne TJ: Changes in hemoglobin level distribution in US dialysis patients fromJune 2006 to November 2008. Am J Kidney Dis 55: 113-120, 2010
19. Practice Monitor DOPPS: Reporting contemporary trends in US dialysis practice. Available at: http://www.dopps.org/DPM/. Accessed August 19, 2011
20. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and supplies. Final rule. Fed Regist 76: 70228-70316, 2011
21. Ibrahim HN, Ishani A, Foley RN, Guo H, Liu J, Collins AJ: Temporal trends in red blood transfusion among US dialysis patients, 1992-2005. Am J Kidney Dis 52: 1115-1121, 2008
22. Chien AT, Li Z, Rosenthal MB: Improving timely childhood immunizations through pay for performance in Medicaid-managed care. Health Serv Res 45: 1934-1947, 2010
23. Jha AK, Orav EJ, Epstein AM: The effect of financial incentives on hospitals that serve poor patients. Ann Intern Med 153: 299-306, 2010
24. Li YH, Tsai WC, Khan M, Yang WT, Lee TF, Wu YC, Kung PT: The effects of pay-for-performance on tuberculosis treatment in Taiwan. Health Policy Plan 25: 334-341, 2010
25. Oluwatowoju I, Abu E, Wild SH, Byrne CD: Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: A regional 2-year audit of diabetes care in the UK. Diabet Med 27: 354-359, 2010
26. Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M: Effects of pay for performance on the quality of primary care in England. N Engl J Med 361: 368-378, 2009
27. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB: Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: Interrupted time series study. BMJ 342: d108, 2011
28. Dalton AR, Alshamsan R, Majeed A, Millett C: Exclusion of patients from quality measurement of diabetes care in the UK payfor-performance programme. Diabet Med 28: 525-531, 2011
29. Tollen L: Physician organization in relation to quality and efficiency of care:a synthesis of recent literature. New York: The Commonwealth Fund; 2008. Available at: http://www.commonwealthfund. org/Publications/Fund-Reports/2008/Apr/Physician-Organizationin-Relation-to-Quality-and-Efficiency-of-Care-A-Synthesis-of-Recent-Literatu.aspx. Accessed May 5, 2012
30. Kochevar JJ, Brotherton S, Dunning SC, Emerson L, Gilbertson D, Harrison D, McClellan A, McClellan W, Stephens JM, Wan S, Gitlin M: The End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) and access to care: Incremental distance traveled by displaced patients [Abstract]. J Am Soc Nephrol 22: 727A, SA-PO2640, 2011
31. Desai AA, Bolus R, Nissenson A, ChertowGM, Bolus S, Solomon MD, Khawar OS, Talley J, Spiegel BM: Is there "cherry picking" in the ESRD program? Perceptions from a dialysis provider survey. Clin J Am Soc Nephrol 4: 772-777, 2009
32. Lacson E Jr, WangW, DeVries C, Leste K, Hakim RM, Lazarus M, Pulliam J: Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am J Kidney Dis 58: 235-242, 2011
33. Miskulin DC, Weiner DE, Tighiouart H, Ladik V, Servilla K, Zager PG, Martin A, Johnson HK, Meyer KB; Medical Directors of Dialysis Clinic Inc: Computerized decision support for EPO dosing in hemodialysis patients. Am J Kidney Dis 54: 1081-1088, 2009
34. Brimble KS, Rabbat CG, McKenna P, Lambert K, Carlisle EJ: Protocolized anemia management with erythropoietin in hemodialysis patients: A randomized controlled trial. J AmSoc Nephrol 14: 2654-2661, 2003
35. Chan K, Moran J, Hlatky M, Lafayette R: Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients. Nephrol Dial Transplant 24: 1956-1962, 2009